161 related articles for article (PubMed ID: 12873719)
1. The XRCC1 codon 399 Gln allele is associated with adenine to guanine p53 mutations in non-small cell lung cancer.
Casse C; Hu YC; Ahrendt SA
Mutat Res; 2003 Jul; 528(1-2):19-27. PubMed ID: 12873719
[TBL] [Abstract][Full Text] [Related]
2. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
[TBL] [Abstract][Full Text] [Related]
3. The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians.
Natukula K; Jamil K; Pingali UR; Attili VS; Madireddy UR
Asian Pac J Cancer Prev; 2013; 14(9):5275-9. PubMed ID: 24175813
[TBL] [Abstract][Full Text] [Related]
4. The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung.
Divine KK; Gilliland FD; Crowell RE; Stidley CA; Bocklage TJ; Cook DL; Belinsky SA
Mutat Res; 2001 Jan; 461(4):273-8. PubMed ID: 11104903
[TBL] [Abstract][Full Text] [Related]
5. hOGG1 Ser326Cys polymorphism and G:C-to-T:A mutations: no evidence for a role in tobacco-related non small cell lung cancer.
Hu YC; Ahrendt SA
Int J Cancer; 2005 Apr; 114(3):387-93. PubMed ID: 15551330
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer.
Park JY; Lee SY; Jeon HS; Bae NC; Chae SC; Joo S; Kim CH; Park JH; Kam S; Kim IS; Jung TH
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):23-7. PubMed ID: 11815397
[TBL] [Abstract][Full Text] [Related]
7. The XRCC1 399Gln polymorphism and the frequency of p53 mutations in Taiwanese oral squamous cell carcinomas.
Hsieh LL; Chien HT; Chen IH; Liao CT; Wang HM; Jung SM; Wang PF; Chang JT; Chen MC; Cheng AJ
Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):439-43. PubMed ID: 12750239
[TBL] [Abstract][Full Text] [Related]
8. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma.
Duell EJ; Holly EA; Bracci PM; Wiencke JK; Kelsey KT
Cancer Res; 2002 Aug; 62(16):4630-6. PubMed ID: 12183419
[TBL] [Abstract][Full Text] [Related]
9. The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms.
Liu G; Zhou W; Park S; Wang LI; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer; 2004 Dec; 101(12):2802-8. PubMed ID: 15534883
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers.
Gao WM; Romkes M; Siegfried JM; Luketich JD; Keohavong P
Mol Carcinog; 2006 Nov; 45(11):828-32. PubMed ID: 16865671
[TBL] [Abstract][Full Text] [Related]
11. Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers.
Lei YC; Hwang SJ; Chang CC; Kuo HW; Luo JC; Chang MJ; Cheng TJ
Mutat Res; 2002 Aug; 519(1-2):93-101. PubMed ID: 12160895
[TBL] [Abstract][Full Text] [Related]
12. Gene polymorphism of DNA repair gene X-ray repair cross complementing group 1 and xeroderma pigmentosum group D and environment interaction in non-small-cell lung cancer for Chinese nonsmoking female patients.
Wang L; Wang LL; Shang D; Yin SJ; Sun LL; Wang XY; Ji HB
Kaohsiung J Med Sci; 2019 Jan; 35(1):39-48. PubMed ID: 30844146
[TBL] [Abstract][Full Text] [Related]
13. [Effect of the XRCC1 and XRCC3 genetic polymorphisms on the efficacy of platinum-based chemotherapy in patients with advanced non-small cell lung cancer].
Xu C; Wang X; Zhang Y; Li L
Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):912-7. PubMed ID: 22152690
[TBL] [Abstract][Full Text] [Related]
14. Association between polymorphisms of DNA repair gene XRCC1 and DNA damage in asbestos-exposed workers.
Zhao XH; Jia G; Liu YQ; Liu SW; Yan L; Jin Y; Liu N
Biomed Environ Sci; 2006 Jun; 19(3):232-8. PubMed ID: 16944782
[TBL] [Abstract][Full Text] [Related]
15. DNA repair gene polymorphisms and benefit from gefitinib in never-smokers with lung adenocarcinoma.
Han JY; Yoon KA; Park JH; Lee YJ; Lee GK; Han JH; Yoon SJ; Yun T; Kim HT; Lee JS
Cancer; 2011 Jul; 117(14):3201-8. PubMed ID: 21264830
[TBL] [Abstract][Full Text] [Related]
16. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
Hu Y; McDermott MP; Ahrendt SA
Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
[TBL] [Abstract][Full Text] [Related]
17. XRCC1 polymorphism and lung cancer risk.
Schneider J; Classen V; Helmig S
Expert Rev Mol Diagn; 2008 Nov; 8(6):761-80. PubMed ID: 18999926
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy.
Huang SP; Huang CY; Wang JS; Liu CC; Pu YS; Yu HJ; Yu CC; Wu TT; Huang CH; Wu WJ; Chou YH; Wu MT
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6632-8. PubMed ID: 18006764
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the DNA repair gene XRCC1 and breast cancer.
Duell EJ; Millikan RC; Pittman GS; Winkel S; Lunn RM; Tse CK; Eaton A; Mohrenweiser HW; Newman B; Bell DA
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):217-22. PubMed ID: 11303590
[TBL] [Abstract][Full Text] [Related]
20. XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies.
Dai L; Duan F; Wang P; Song C; Wang K; Zhang J
Mol Biol Rep; 2012 Oct; 39(10):9535-47. PubMed ID: 22729882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]